- Stocks
- Healthcare
- NASDAQ: CDMO

Price (delayed)

$17.8

Market cap

$1.11B

P/E Ratio

9.37

Dividend/share

N/A

EPS

$1.9

Enterprise value

$1.23B

Avid Bioservices is a dedicated contract development and manufacturing organization (CDMO) focused on development and CGMP manufacturing of biopharmaceutical drug substances derived from mammalian cell culture. The company provides a

CDMO's revenue is up by 21% year-on-year and by 4.9% since the previous quarter

Avid Bioservices's equity has increased by 2.3% QoQ

CDMO's gross profit is down by 20% year-on-year but it is up by 2.5% since the previous quarter

Avid Bioservices's quick ratio has plunged by 63% YoY and by 28% from the previous quarter

Avid Bioservices's gross margin has decreased by 34% YoY and by 2.3% from the previous quarter

What are the main financial stats of CDMO

Market
Valuations
Earnings

Shares outstanding

62.55M

Market cap

$1.11B

Enterprise value

$1.23B

Price to earnings (P/E)

9.37

Price to book (P/B)

5.98

Price to sales (P/S)

7.89

EV/EBIT

271.88

EV/EBITDA

109.34

EV/Sales

8.77

Revenue

$140.69M

EBIT

$4.54M

EBITDA

$11.28M

Free cash flow

-$92.4M

Per share
Balance sheet
Liquidity

EPS

$1.9

Free cash flow per share

-$1.48

Book value per share

$2.98

Revenue per share

$2.26

TBVPS

$7.22

Total assets

$450.43M

Total liabilities

$265.04M

Debt

$180.74M

Equity

$185.4M

Working capital

$45.02M

Debt to equity

0.97

Current ratio

1.52

Quick ratio

0.86

Net debt/EBITDA

10.68

Margins
Efficiency
Dividend

EBITDA margin

8%

Gross margin

21.4%

Net margin

82.8%

Operating margin

2.7%

Return on assets

26.3%

Return on equity

64.7%

Return on invested capital

1%

Return on capital employed

1.2%

Return on sales

3.2%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Avid Bioservices stock price performed over time

Intraday

-2.14%

1 week

27.6%

1 month

7.55%

1 year

-17.21%

YTD

29.27%

QTD

29.27%

How have Avid Bioservices's revenue and profit performed over time

Revenue

$140.69M

Gross profit

$30.07M

Operating income

$3.84M

Net income

$116.47M

Gross margin

21.4%

Net margin

82.8%

The operating margin has dropped by 82% year-on-year and by 18% since the previous quarter

The operating income has plunged by 78% YoY and by 13% from the previous quarter

Avid Bioservices's gross margin has decreased by 34% YoY and by 2.3% from the previous quarter

CDMO's revenue is up by 21% year-on-year and by 4.9% since the previous quarter

What is Avid Bioservices's growth rate over time

What is Avid Bioservices stock price valuation

P/E

9.37

P/B

5.98

P/S

7.89

EV/EBIT

271.88

EV/EBITDA

109.34

EV/Sales

8.77

CDMO's price to earnings (P/E) is 13% higher than its last 4 quarters average of 8.3

CDMO's price to book (P/B) is 44% less than its 5-year quarterly average of 10.6 but 4.9% more than its last 4 quarters average of 5.7

Avid Bioservices's equity has increased by 2.3% QoQ

CDMO's revenue is up by 21% year-on-year and by 4.9% since the previous quarter

CDMO's P/S is 2.6% below its 5-year quarterly average of 8.1

How efficient is Avid Bioservices business performance

Avid Bioservices's return on invested capital has shrunk by 87% YoY and by 9% QoQ

The company's return on sales has shrunk by 79% YoY

CDMO's return on equity is down by 19% since the previous quarter

The return on assets has declined by 9% since the previous quarter

What is CDMO's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for CDMO.

How did Avid Bioservices financials performed over time

The total assets is 70% greater than the total liabilities

Avid Bioservices's quick ratio has plunged by 63% YoY and by 28% from the previous quarter

The total assets is up by 43% year-on-year

The company's debt is 2.5% lower than its equity

The debt to equity has plunged by 70% YoY and by 3% from the previous quarter

Avid Bioservices's equity has increased by 2.3% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.